Human hepatoma cells HepG2, which did not express IDO1 in vitro, were subcutaneously implanted into non-obese diabetic/severe combined immunocompromised (NOD/SCID) mice (Figure 4A and Figure 5). This evidence concerns the gene IDO1 and hepatocellular carcinoma.